WEDNESDAY, April 28, 2021 — Only 13.5% of people will suffer systemic side effects after getting Pfizer’s coronavirus vaccine, a new study finds. These systemic symptoms include headache, fatigue and tenderness. Most side effects are mild and peak in the day after being vaccinated, and they only last for one to two days, according to… Read More »
March 26, 2020, the World Health Organization (WHO) tweeted a post against the use of masks for the general public: “If you do not have any respiratory symptoms, such as fever, cough, or runny nose, you do not need to wear a medical mask. When used alone, masks can give you a false feeling of… Read More »
A study of gay and bisexual male participants in the first large implementation study of HIV pre-exposure prophylaxis (PrEP) in Australia has found that although rates of bacterial sexually transmitted infections (STIs) were high, they did not increase in the two years after starting PrEP. In contrast, they increased significantly in the year before men… Read More »
The first randomized controlled trial1,2 to assess the effectiveness of surgical face masks against SARS-CoV-2 infection specifically — which journals initially refused to publish — is finally seeing the light of day. The so-called “Danmask-19 Trial,” published November 18, 2020, in the Annals of Internal Medicine,3 included 3,030 individuals assigned to wear a surgical face… Read More »
France and Germany have turned to forms of lockdown to control the virus. BBC News – Health
Exposure to child care was not associated with a heightened risk of coronavirus infection for providers, according to what authors say is the largest study of its kind. Researchers from Yale University gathered data from over 57,000 child care providers in the U.S. amid the first several months in the pandemic to assess for an… Read More »
After Pfizer’s Ibrance failed a crucial study in HR-positive, HR-negative postsurgery breast cancer patients, the company clung to hope that it could still show a benefit in a high-risk subset of those patients. But new data have officially snuffed out those hopes. There’s “no saving adjuvant for Ibrance,” SVB Leerink analyst Geoffrey Porges wrote in… Read More »
TestBoston, a large-scale research study that will facilitate at-home testing for both the SARS-CoV-2 virus and antibodies against it, is accepting applications from 10,000 current and former Brigham and Women’s Hospital patients. Researchers from Harvard-affiliated Brigham, the Broad Institute of MIT and Harvard, and the MGB Center for COVID Innovation said the test will detect… Read More »